A cross-sectional study to analyze the pattern of pharmacotherapy and its associated factors among patients with schizophrenia
Background: Schizophrenia, a severe chronic mental disorder, is primarily treated with pharmacotherapy, typically involving either first-generation antipsychotics (FGA) or second-generation antipsychotics (SGA) or a combination of both. The selection of antipsychotics, transitions between medication...
Saved in:
| Main Authors: | B. S. Abhishree, Shreya Bhat, Sushma Muraraiah, Kavitha Rajarathna |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
| Series: | Telangana Journal of Psychiatry |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/tjp.tjp_23_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Population Pharmacokinetics of Risperidone and Paliperidone in Schizophrenia: A Systematic Review
by: Ana Carrascosa-Arteaga, et al.
Published: (2025-05-01) -
Antipsychotic and pharmacogenomic effects on cross-sectional symptom severity and cognitive ability in schizophreniaResearch in context
by: Siobhan K. Lock, et al.
Published: (2025-06-01) -
Antipsychotic polypharmacy in clozapine resistant schizophrenia: a randomized controlled trial of tapering antipsychotic co-treatment
by: Jari Tiihonen, et al.
Published: (2012-01-01) -
Treatment of a schizophrenia patient on long-term super-dose antipsychotics: a case report
by: Xiaobo Xie, et al.
Published: (2025-01-01) -
Deterioration of COVID-19 vaccine efficacy by antipsychotic medications in schizophrenia patients
by: Takashi Kusunoki, et al.
Published: (2025-05-01)